CCR4 Expression in Tumor-Infiltrating Regulatory T Cells in Patients with Squamous Cell Carcinoma of the Lung: A Prognostic Factor for Relapse and Survival

Cancer Invest. 2019;37(3):163-173. doi: 10.1080/07357907.2019.1582848. Epub 2019 Mar 25.

Abstract

To clarify the prognostic impact of tumor-infiltrating effector regulatory T cells (eTregs) in non-small cell lung cancer (NSCLC), eTregs were evaluated by immunohistochemical detection of CCR4 and Foxp3 in 108 consecutive surgical NSCLC tumors. Multivariate analysis showed that a high ratio of CCR4+ eTregs to total Tregs (≥40%) was the only independent risk factor for relapse-free survival (odds ratio [OR]: 6.54, 95% confidence interval: 1.67-25.7, p = .007) and overall survival (OR: 3.76, p = .037) in lung squamous cell carcinoma (SqCC). These results highlight the prognostic importance of the balance of tumor-infiltrating Tregs in resected lung SqCC.

Keywords: CCR4; Foxp3; Non-small cell lung cancer; Regulatory T cell; Squamous cell carcinoma of the lung.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Non-Small-Cell Lung / diagnosis
  • Carcinoma, Non-Small-Cell Lung / metabolism*
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / metabolism*
  • Disease-Free Survival
  • Female
  • Humans
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / metabolism*
  • Lymphocytes, Tumor-Infiltrating / metabolism*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Prognosis
  • Receptors, CCR4 / biosynthesis*
  • T-Lymphocytes, Regulatory / metabolism*

Substances

  • CCR4 protein, human
  • Receptors, CCR4